UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl)
UvA-DARE (Digital Academic Repository)
Limitations of current antiretroviral therapy in HIV-1 infection: the search for new
strategies
Sankatsing, S.U.C.
Publication date
2004
Link to publication
Citation for published version (APA):
Sankatsing, S. U. C. (2004). Limitations of current antiretroviral therapy in HIV-1 infection: the
search for new strategies.
General rights
It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons).
Disclaimer/Complaints regulations
If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible.
ListList of publications
Sankatsingg S.U.C.. Prins JM. Agranulocytosis and fever seven weeks after
startingg abacavir. AIDS. 2001 ;15: 2464-5.
Sankatsingg S.U.C.. Droste J., Burger D., Van Praag R.M.E., Jurriaans S.,
Langee J.M., Prins J.M. Limited penetration of lopinavir into seminal plasma of HIV-1-infectedd men. AIDS 2002;16:1698-700.
Sankatsingg S.U.C.. Van Praag R.M.E., Van Rij R.P., Rientsma R., Jurriaans
S.,, Lange J.M.A., Prins J.M. and Schuitemaker H. Dynamics of the pool of infectedd resting CD4 HLA-DR" T lymphocytes in patients who started a triple classs five-drug antiretroviral regimen during primary HIV-1 infection. Antiviral Therapyy 2003;8:137-42.
Sankatsingg S.U.C., Weverling G.J., Peeters M., Van 't Klooster G., Gruzdev
B.,, Rakhmanova A., Danner S.A., Jurriaans S., Prins J.M. and Lange J.M.A. TMC1255 exerts similar initial antiviral potency as a five-drug, triple class antiretrovirall regimen. AIDS 2003;17:2623-2627.
Sankatsingg S.U.C.. Beijnen J.H., Schinkel A.H., Lange J.M.A., Prins J.M.
P-glycoproteinn in human immunodeficiency virus type 1 infection and therapy. Antimicrobiall Agents & Chemotherapy 2004;48:1073-1081.
Jurriaanss S., Sankatsing S.U.C., Prins J.M., Schuitemaker H., van der Kuyl A.C.,, Cornelissen M. HIV-1 seroreversion after HAART in a HIV-1 seropositive immunocompetentt patient. AIDS, accepted for publication.
Sankatsingg S.U.C.. Hoggard P.G., Huitema A.D.R., Sparidans R.W., Kewn
S.,, Crommentuyn K.M.L., Lange J.M.A., Beijen J.H., Back D.J., Prins J.M. Effectt of mycophenolate mofetil on the pharmacokinetics of antiretroviral drugss and the intracellular nucleoside triphosphate pools. Clinical Pharmacokinetics,, accepted for publication.
ListList of publications
Lowee S.H., Sankatsinq S.U.C.. Repping S., van der Veen F., Reiss P., Lange J.M.A.,, Prins J.M. Is the male genital tract really a sanctuary site for HIV? Argumentss that it is not. AIDS, accepted for publication.
Sankatsinqq S.U.C.. Jurriaans S, van Swieten P, van Leth F., Comelissen M.,
Miedemaa F., Lange J.M.A., Schuitemaker H., Prins J.M. Highly active antiretrovirall therapy with or without mycophenolate mofetil in treatment naïve HIV-11 patients. Submitted for publication.
Jansenn CA., De Cuyper I.M., Steingrover R., Jurriaans S., Sankatsinq
S.U.C... Prins J.M., Lange J.M.A., van Baarte D., Miedema F.
Preservationn of HIV-specific CD4+ T cell cytokine production and proliferation byy HAART during acute HIV-1 infection. Submitted for publication.
Vrisekoopp N., Sankatsinq S.U.C.. Jansen CA., Roos M.T.L., Otto S.A., Schuitemakerr H., Lange J.M.A., Prins J.M., Miedema F. No detrimental immunologicall effects of mycophenolate mofetil and HAART in treatment naïvee acute and chronic HIV-1 infected patients. Submitted for publication.
Sankatsinqq S.U.C.. Comelissen M., Kloosterboer N., Crommentuyn K.M.L.,
Boschh T.M., Jurriaans S.T Huitema A.D.R., Beijen J.H., Lange J.M.A., Prins J.M.,, Schuitemaker H. Antiviral activity of HIV-1 protease inhibitors nelfinavir andd indinavir in vivo is not influenced by P-glycoprotein activity on CD4+ T-cells.. Submitted for publication.
H H
